Nalmefene for daily consumption of alcohol - 13/04/16
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 2 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Résumé |
Introduction |
The level of high-risk alcohol consumption WHO is estimated at more than 40mg for women and 60mg for men.
Nalmefene is a new treatment that breaks the cycle of continued use of alcohol.
Methodology |
A sample of 18 patients of a Mental Health Centre in the province of Leon alcohol dependent and high consumption They received nalmefene 18mg daily continuous treatment for 6–9 months is selected. We appreciate the adherence of patients and the efficacy, tolerability and impact on physical health.
Results |
We appreciate reduction in the amount of alcohol ingested observed by both the patient and their relatives without any cases of neglect and few side effects.
We got two patients leave the alcohol completely and an average decline in consumption over 9 Basic Units of Drink.* (90 g).
We observed improvement in the quality of life in patients with multiple pathologies and difficult social situation.
Le texte complet de cet article est disponible en PDF.Plan
Vol 33 - N° S
P. S320-S321 - mars 2016 Retour au numéro
Article précédent
- Cognitive factors in social adaptation of opium addicts in remission
- L. Tursunkhodjaeva, L. Muzaffarova
- A case of marchiafava bignami disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms
- C. Vecchi, C. Gramaglia, A. Feggi, I. Coppola, S. Di Marco, A. Venesia, C. Delicato, N. Chieppa, F. De Marchi, R. Cantello, P. Zeppegno
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?